Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations

This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.


Life Saving Drugs Program – Pompe disease – Medicines review summary

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
General public

Help us improve

If you would like a response please use the enquiries form instead.